155 related articles for article (PubMed ID: 12619060)
1. Mitochondrial DNA alterations in thyroid cancer.
Tong BC; Ha PK; Dhir K; Xing M; Westra WH; Sidransky D; Califano JA
J Surg Oncol; 2003 Mar; 82(3):170-3. PubMed ID: 12619060
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
[TBL] [Abstract][Full Text] [Related]
3. Infrequent CDKN2 mutation in human differentiated thyroid cancers.
Tung WS; Shevlin DW; Bartsch D; Norton JA; Wells SA; Goodfellow PJ
Mol Carcinog; 1996 Jan; 15(1):5-10. PubMed ID: 8561866
[TBL] [Abstract][Full Text] [Related]
4. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
5. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
7. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors.
Sanchez-Cespedes M; Parrella P; Nomoto S; Cohen D; Xiao Y; Esteller M; Jeronimo C; Jordan RC; Nicol T; Koch WM; Schoenberg M; Mazzarelli P; Fazio VM; Sidransky D
Cancer Res; 2001 Oct; 61(19):7015-9. PubMed ID: 11585726
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic instabilities of thyroid and colon cancers.
Stoler DL; Nowak NJ; Matsui S; Wiseman SM; Chen N; Dutt SS; Bartos JD; Loree TR; Rigual NR; Hicks WL; Sait SN; Anderson GR
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):457-63. PubMed ID: 17515504
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
10. DNA copy number changes in thyroid carcinoma.
Hemmer S; Wasenius VM; Knuutila S; Franssila K; Joensuu H
Am J Pathol; 1999 May; 154(5):1539-47. PubMed ID: 10329606
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.
Di Cristofaro J; Marcy M; Vasko V; Sebag F; Fakhry N; Wynford-Thomas D; De Micco C
Hum Pathol; 2006 Jul; 37(7):824-30. PubMed ID: 16784981
[TBL] [Abstract][Full Text] [Related]
12. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
[TBL] [Abstract][Full Text] [Related]
13. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.
Yeh JJ; Lunetta KL; van Orsouw NJ; Moore FD; Mutter GL; Vijg J; Dahia PL; Eng C
Oncogene; 2000 Apr; 19(16):2060-6. PubMed ID: 10803467
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of mutations in thyroid tumors with TGGE.
Simon D; Goretzki PE; Schäfer C; Gorelov V; Ebeling B; Röher HD
Exp Clin Endocrinol Diabetes; 1995; 103(5):275-9. PubMed ID: 8536054
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the mitochondrial displacement loop in lung cancers.
Suzuki M; Toyooka S; Miyajima K; Iizasa T; Fujisawa T; Bekele NB; Gazdar AF
Clin Cancer Res; 2003 Nov; 9(15):5636-41. PubMed ID: 14654546
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
19. MET receptor tyrosine kinase sequence alterations in differentiated thyroid carcinoma.
Wasenius VM; Hemmer S; Karjalainen-Lindsberg ML; Nupponen NN; Franssila K; Joensuu H
Am J Surg Pathol; 2005 Apr; 29(4):544-9. PubMed ID: 15767811
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid cancer: high inter-(simple sequence repeat) genomic instability in a typically indolent cancer.
Wiseman SM; Loree TR; Rigual NR; Hicks WL; Winston JS; Swede H; Bartos JD; Anderson GR; Stoler DL
Head Neck; 2003 Oct; 25(10):825-32. PubMed ID: 12966506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
